Literature DB >> 29071537

Major Gastric Haemorrhage After Intragastric Balloon Insertion: Case Report.

Romy J Granek1, Michael W Hii2, Salena M Ward2.   

Abstract

Intragastric balloons are a minimally invasive option for weight loss. They are generally well tolerated and rarely associated with serious adverse events. We report a case of major upper gastrointestinal haemorrhage after insertion of an Orbera® intragastric balloon.

Entities:  

Keywords:  Complications; Endoscopy; Haemorrhage; Intragastric balloon; Morbid obesity

Mesh：

Year:  2018        PMID： 29071537     DOI： 10.1007/s11695-017-2988-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


  17 in total

Review 1.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

Review 2.  Intragastric Balloon Treatment for Obesity: Review of Recent Studies.

Authors:  Chinara M Tate; Allan Geliebter
Journal:  Adv Ther       Date:  2017-07-13       Impact factor: 3.845

Review 3.  Intragastric balloon therapy in the management of obesity: why the bad wrap?

Authors:  Joshua T Evans; Mark H DeLegge
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-01       Impact factor: 4.016

4.  Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis.

Authors:  Hiroki Ikeuchi; Kazutoshi Hori; Takashi Nishigami; Hiroki Nakano; Motoi Uchino; Mitsuhiro Nakamura; Nobuaki Kaibe; Masafumi Noda; Hidenori Yanagi; Takehira Yamamura
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

5.  Small bowel obstruction due to air-filled intragastric balloon.

Authors:  Zafer S Matar; Abbas A Mohamed; Muhammad Abukhater; Mobarak Hussien; Fawaz Emran; Nadeem A Bhat
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

Review 6.  Upper gastrointestinal Crohn's disease.

Authors:  Christian Mottet; Pascal Juillerat; Valérie Pittet; Jean-Jacques Gonvers; Pierre Michetti; John-Paul Vader; Christian Felley; Florian Froehlich
Journal:  Digestion       Date:  2008-02-07       Impact factor: 3.216

Review 7.  ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.

Authors:  Barham K Abu Dayyeh; Nitin Kumar; Steven A Edmundowicz; Sreenivasa Jonnalagadda; Michael Larsen; Shelby Sullivan; Christopher C Thompson; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2015-07-29       Impact factor: 9.427

Review 8.  Intragastric balloon for obesity.

Authors:  M Fernandes; A N Atallah; B G O Soares; S Humberto; S Guimarães; D Matos; L Monteiro; B Richter
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

9.  Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.

Authors:  Rena R Wing; Wei Lang; Thomas A Wadden; Monika Safford; William C Knowler; Alain G Bertoni; James O Hill; Frederick L Brancati; Anne Peters; Lynne Wagenknecht
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112

10.  Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management.

Authors:  Evzen Machytka; Pavel Klvana; Asher Kornbluth; Steven Peikin; Lisbeth E M Mathus-Vliegen; Christopher Gostout; Gontrand Lopez-Nava; Scott Shikora; Jeffrey Brooks
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.